Cargando…
P316: PRIORITIZING PRECISION MEDICINES IN PEDIATRIC BLOOD CANCER: EXPERIENCE OF THE DUTCH INDIVIDUALIZED THERAPY (ITHER) STUDY’S MOLECULAR TUMOR BOARD
Autores principales: | Boer, Judith M., Ilan, Uri, Hoen, Babette D.J., Boeree, Aurelie, Langenberg, Karin P.S., Koster, Jan, Bourquin, Jean-Pierre, Molenaar, Jan J., Goemans, Bianca, den Boer, Monique L., Zwaan, Michel |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10428480/ http://dx.doi.org/10.1097/01.HS9.0000968176.08568.30 |
Ejemplares similares
-
Implementation of paediatric precision oncology into clinical practice: The Individualized Therapies for Children with cancer program ‘iTHER’
por: Langenberg, Karin P.S., et al.
Publicado: (2022) -
W(H)ither the Golgi during Mitosis?
por: Nelson, W. James
Publicado: (2000) -
PB1725: INTERNATIONAL LEUKEMIA TARGET BOARD - A PLATFORM TO DISCUSS AND PRIORITIZE TARGETED TREATMENT OPTIONS FOR PATIENTS WITH RELAPSED/REFRACTORY PEDIATRIC HEMATOLOGICAL MALIGNANCIES (ILTB) – ITCC 107
por: Ilan, Uri, et al.
Publicado: (2023) -
50 Years on, w(h)ither the Ramsar convention? A case of institutional drift
por: Bridgewater, Peter, et al.
Publicado: (2021) -
Dutch teratological collections and their artistic portrayals
por: Boer, Lucas L., et al.
Publicado: (2021)